Magnesium therapy for nephrolithiasis

Magnesium Research

Volumn 18, Issue 2, 2005, Pages 123-126

  Massey, L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Calcium; Magnesium; Nephrolithiasis; Oxalate

Indexed keywords

CALCIUM OXALATE; MAGNESIUM; MAGNESIUM HYDROXIDE; MAGNESIUM OXIDE;

CLINICAL TRIAL; CRYSTALLIZATION; DRUG ANTAGONISM; HUMAN; NEPHROLITHIASIS; REVIEW;

CALCIUM OXALATE; CLINICAL TRIALS; CRYSTALLIZATION; HUMANS; KIDNEY CALCULI; MAGNESIUM; MAGNESIUM HYDROXIDE; MAGNESIUM OXIDE;

EID: 23244445745     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Tiselius HG. Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Res 1991 ; 47 : 255-9.
2. Borghi L, Meschi T, Guerra A, Beramaschi E, Mutti A, Novarini A. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin Chim Acta 1995 ; 239 : 1-11.
3. Tiselius HG. Factors influencing the course of calcium oxalate stone disease. Eur Urol 1999 ; 36 : 363-70.
4. Rodgers A. Aspects of calcium oxalate crystallization : Theory, in vitro studies and in vivo implementation. J Am Soc Nephrol 1999 ; 10 : S351-S354.
5. Allie S, Rodgers A. Effects of calcium carbonate, magnesium oxide and sodium citrate bicarbonate health supplements on the urinary risk factors for kidney stone formation. Clin Chem Lab Med 2003 ; 41 : 39-45.
6. Liebman M, Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 2000 ; 163 : 1565-9.
7. Berg W, Bothor C, Pirlich W, Janitzky V. Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 1986 ; 12 : 274-82.
8. Ko KW, Fellers FX, Craig JM. Observations on magnesium deficiency in the rat. Lab Inv 1962 ; 11 : 294-305.
9. Khan SR, Shevock PN, Hackett RL. Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis. J Urol 1993 ; 149 : 412-6.
10. Hammarsten G. On calcium oxalate and its solubility in the presence of inorganic salts with special reference to occurrence of crystaluria. CR Trav Lab Carlsberg 1929 ; 17 : 1-85.
11. Thomas T, Durlach J. Déficit magnésique et pathologie du rein. In : 1er Symposium International sur le déficit magnésique en pathologie humaine. 1. Volume des rapports. J Durlach, ed., 359-85.
12. De Albuquerque PF, Tuma M. Investigations on urolithiasis. II. Studies on oxalate. J Urol 1962 ; 87 : 504-6.
13. Moore CA, Bunce GE. Reduction in frequency of renal calculus formation by oral magnesium administration. A preliminary report. Inv Urol 1964 ; 2 : 7-13.
14. Melnick I, Landes RR, Hoffman AA, Burch JF. Magnesium therapy for recurring calcium oxalate urinary calculi. J Urol 1971 ; 105 : 119-22.
15. Johansson G, Backman U, Danielson BG, Fellstrom B, Ljunghall S, Wikstrom B. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 1980 ; 124 : 770-4.
16. Ettinger B, Citron JT, Livermoore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 1988 ; 139 : 679-84.
17. Pak CYC, Koenig K, Khan R, Haynes S, Padalino P. Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Min Res 1992 ; 7 : 281-5.
18. Kato Y, Yamaguchi S, Yachiku S, Nakazono S, Hori JI, Wada N, Hou K. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urol 2004 ; 63 : 7-12.
19. Ettinger B, Pak CYC, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997 ; 158 : 2069-73.
20. Lindberg JS, Zobitz MM, Poindexter JR, Pak CYC. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr 1990 ; 9 : 48-55.
21. Ranade W, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 2001 ; 8 : 345-57.
22. Schwartz BF, Bruce J, Leslie S, Stoller ML. Rethinking the role of urinary magnesium in calcium urolithiasis. J Endourol 2001 ; 15 : 233-5.
23. Preminger GM, Baker S, Peterson R, Poindexter J, Pak CYC. Hypomagnesiuric hypocitraturia : An apparent new entity for calcium nephrolithiasis. J Lithotrypsy Stone Disease 1989 ; 1 : 22-5.
24. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men : New insights after 14 years of follow-up. J Am Soc Nephrol 2004 ; 15 : 3225-32.
25. Chai W, Liebman M. Oxalate content of legumes, nuts and grain-based flours. J Food Composition Analysis 2005 ; (in press).
26. Mendonca C, Martini LA, Baxmann AC, et al. Effects of an oxalate load on urinary oxalate excretion in calcium stone formers. J Ren Nutr 2003 ; 13 : 39-46.